A study suggests zinc holds promise for addressing recurrent thrush, a condition affecting 138 million women worldwide. Current treatments often fail to prevent its recurrence. Lead researcher Dr. Duncan Wilson of the University of Exeter’s MRC Centre for Medical Mycology highlights zinc’s potential in blocking inflammatory responses triggered by the Pra1 molecule associated with thrush. Initial findings showed zinc sulphate in Juviagel prevented reinfection in five out of six women. Fempharma conducts clinical trials to confirm Juviagel’s effectiveness in preventing vaginal yeast infections. This research underscores the importance of basic research in uncovering new treatment pathways and potentially improving women’s health globally.
Home » Zinc’s Potential in Addressing Recurrent Thrush: A Promising Avenue for Women’s Health
Zinc’s Potential in Addressing Recurrent Thrush: A Promising Avenue for Women’s Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Fasting Mimetic Supplement Shows Cardioprotective Promise
November 30, 2024
Breaking the Code: Enzyme TYK2 Offers Hope for Alzheimer’s Treatment
November 30, 2024
Sucrosomial® B12: A Breakthrough in B12 Supplementation
November 30, 2024
Harnessing Beneficial Bacteria: A Breakthrough in UTI Management
November 25, 2024
Activ’Inside’s Belight: A Natural Solution for Skin Hyperpigmentation
November 22, 2024